BD Veritor™ Plus Analyzer


Educational Resources
9 FILE(S)

Physician Education Resources
Overview

BD Veritor™ Plus Analyzer System

Digital clarity:
Unambiguous positive/negative display which may help to reduce result interpretation
errors and streamline diagnosis.
Rapid results:
• Delivers clear digitally read results in 15 minutes or less,* supporting timely clinical decisions.
Easy to use:
• No monthly calibration required, single-button functionality.

Flexible workflow options:
Walk Away mode: Built in timer allows you to perform other tasks throughout test development.
Analyze Now mode: Enables immediate processing to support batch testing.
Compact, lightweight and portable—able to function without cords
Cost-effective:
No service contracts, maintenance or calibration needed for device lifetime

 

BD Veritor™ System for SARS-CoV-2

Simplify COVID testing

For fast, clear and reliable COVID-19 results, when you need them the most.

Discover the portable, easy-to-use BD Veritor ™ Plus System. It provides reliable results in just 15 minutes.1 When your patients need reliable, rapid COVID-19 testing, turn to the BD Veritor ™ Plus System. It offers dependable results at the point of care in a simple-to-operate portable instrument (1 kit = 30 tests).

 

BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B** (EUA) Test
Simplify Respiratory Testing

A 3-in-1 antigen assay for COVID-19, Flu A and Flu B with test results in 15 minutes.2

The BD Veritor™ Plus System streamlines clinical and patient workflows by detecting three key respiratory viruses in one test, reducing the need for multiple sample collections. With multiple testing modes and workflow efficiencies, the analyzer empowers convenience and efficiency (1 kit = 30 tests).

 

BD Veritor™ System for Rapid Detection of RSV (CLIA-waived)

Simplify RSV testing


The portable, easy-to-use BD Veritor ™ Plus System provides reliable RSV results in 10 minutes.3

When your pediatric patients need fast, reliable RSV testing, turn to the BD Veritor ™ Plus
System. Offering reliable results at point of care in a simple-to-operate, handheld instrument. Simple RSV testing for those at highest risk (age restriction infant to under 6 years old) (1 kit = 30 kits). 

 

BD Veritor™ System for Rapid Detection of Group A Strep (CLIA-waived)

Simplify Strep testing

CLIA-waived testing for Group A Strep.
Achieve accurate Group A Strep results in 5 minutes with the portable, easy-to-use BD Veritor ™ Plus System (1 kit= 30 tests).4

 

BD Veritor™ System for Rapid Detection of Flu A+B (CLIA-waived)

Simplify Flu A+B testing

Streamline your point-of-care flu testing with the portable BD Veritor ™ Plus System, which features
intuitive operation and timely, reliable results in 10 minutes.5 The BD Veritor ™ Plus System offers simple operation, efficient workflows, and reliable, traceable results, which may help improve the patient experience (1 kit= 30 tests)

 

*Result processing times for each BD Veritor™ assay are 15 minutes for the SARS-CoV-2 and SARS-CoV-2 & Flu A+B assays, 10 minutes for Flu A+B and RSV assays, and 5 minutes for the Group A Strep assay.

**In the USA, the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B has not been FDA cleared or approved but has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high, or waived complexity tests. The product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens; and, in the USA, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID 19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

The BD Veritor™ RSV CLIA-waived kit is indicated for use in patients under 6 years of age. The BD Veritor™ RSV moderately complex kit is individual for use in patients under 20 years of age.

References

  1. BD Veritor™ System for SARS-CoV-2. Package insert. 500075511(01) Becton, Dickinson and Company.
  2. BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 and Flu A+B. Package insert. 500051910 Becton, Dickinson and Company.
  3. BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus (RSV), package insert, 8086098. Franklin Lakes, NJ: Becton, Dickinson and Company
  4. BD Veritor™ Plus System for Rapid Detection of Group A Strep, laboratory kit [package insert], 8087675. Franklin Lakes, NJ: Becton, Dickinson and Company
  5. BD Veritor™ Plus System for Rapid Detection of Flu A+B. Package insert. 8087667 Becton, Dickinson and Company.

Point-of-care testing for COVID-19, COVID-19 + Flu A+B,** Flu A+B, RSV, and Group A Strep assays